STERiJECT
Contact TSK

FAQ

Frequently asked questions

Common questions about STERiJECT needles.

How does the design of TSK STERiJECT needles minimize patient discomfort?

The design of TSK STERiJECT needles, particularly the larger inner diameter and robust hub material, works in tandem to minimize patient discomfort. The smoother product flow enabled by the TSKiD™ barrels reduces the force required for injection, which can lead to less pain during the procedure. Additionally, the reliable connection and stability of the hard polymer hub ensure accurate delivery, further enhancing patient comfort during treatments.

Clinical Evidence

What measures are taken to ensure the safety and sterility of the TSK STERiJECT Needle?

The TSK STERiJECT Needle is manufactured under stringent quality control standards to ensure safety and sterility. Each needle is individually packaged and sterilized, meeting international safety regulations. Practitioners can have confidence that each needle is ready for use in a sterile environment, minimizing the risk of infection during injections.

Is the STERiJECT Ophthalmic Needle FDA cleared, and how is it controlled for particulates and endotoxin?

Yes. The STERiJECT Ophthalmic Needle is FDA 510(k) cleared for ophthalmic injections. It is also held to far stricter contamination limits than regular hypodermic needles: an endotoxin limit of 0.2 EU per device compared to the 20.0 EU allowed for regular needles, and compliance with the USP <789> particulate standard, which regular needles are not tested against. These controls matter for intravitreal injections, where even trace contaminants can pose a risk to the eye, and they give practitioners confidence that every needle meets the safety and quality standards required for ophthalmic procedures.

VLDS Clinical Evidence

What makes STERiJECT needles different from conventional needles?

STERiJECT families are engineered around different clinical and delivery requirements. STERiJECT combines specialized technologies such as low-dead-space hubs, thin-wall cannulas, and advanced hub designs.

Our Innovations

Why does low dead space matter when delivering small-volume or high-value drugs?

With small injection volumes, residual volume in the needle and hub can represent a meaningful portion of the intended dose. STERiJECT low-dead-space designs minimize the volume retained in the hub, supporting more accurate dose delivery and reducing product loss.

LDS VLDS

Which STERiJECT needle configuration should I choose?

It depends on the procedure, formulation and performance requirements. VLDS is the ophthalmic-cleared low-dead-space option; LDS focuses on minimizing residual volume across broader applications; HPC is engineered for flow and connection security under higher pressures; and PRE provides a versatile range of gauges and lengths.

Product Comparison

Can I get samples to evaluate STERiJECT with my syringe, drug or procedure?

Product samples may be available to qualified healthcare professionals and organizations for evaluation. Availability, quantity, pricing, shipping charges, documentation, and ordering requirements vary by product and region. After reviewing your request, our team will contact you to confirm the appropriate STERiJECT product and any applicable costs.

Contact

Next step

Ask us about your procedure